Advertisement

More articles from Biology of Human Tumors

  • LDHA and aerobic glycolysis in neuroblastoma
    Carmen Dorneburg, Matthias Fischer, Thomas F.E. Barth, Wolfgang Mueller-Klieser, Barbara Hero, Judith Gecht, Daniel R Carter, Katleen De Preter, Benjamin Mayer, Lisa Christner, Frank Speleman, Glenn M Marshall, Klaus-Michael Debatin, Christian Beltinger
    Clinical Cancer Research Jan 2018, clincanres.2578.2017; DOI: 10.1158/1078-0432.CCR-17-2578
  • Metastatic Nature of Uterine Cancers with Leukocytosis
    Tomoyuki Sasano, Seiji Mabuchi, Katsumi Kozasa, Hiromasa Kuroda, Mahiru Kawano, Ryoko Takahashi, Naoko Komura, Eriko Yokoi, Yuri Matsumoto, Kae Hashimoto, Kenjiro Sawada, Eiichi Morii, Tadashi Kimura
    Clinical Cancer Research May 2018, DOI: 10.1158/1078-0432.CCR-17-2472
  • CAFs affect tumor-infiltrating lymphocytes via IL-6
    Takuya Kato, Kazuhiro Noma, Toshiaki Ohara, Hajime Kashima, Yuki Katsura, Hiroaki Sato, Satoshi Komoto, Ryoichi Katsube, Takayuki Ninomiya, Hiroshi Tazawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara
    Clinical Cancer Research Jan 2018, clincanres.0205.2018; DOI: 10.1158/1078-0432.CCR-18-0205
  • CD16+/CD11b+ PMN-MDSC in head and neck cancer
    Stephan Lang, Kirsten Bruderek, Cordelia Kaspar, Benedikt Höing, Oliver Kanaan, Nina Dominas, Timon Hussain, Freya Droege, Christian Peter Eyth, Boris Hadaschik, Sven Brandau
    Clinical Cancer Research Jan 2018, clincanres.3726.2017; DOI: 10.1158/1078-0432.CCR-17-3726
  • Oncogenic function of FEZF1-AS1 in colorectal cancer
    Zehua Bian, Jiwei Zhang, Min Li, Yuyang Feng, Xue Wang, Jia Zhang, Surui Yao, Guoying Jin, Jun Du, Weifeng Han, Yuan Yin, Shenglin Huang, Bojian Fei, Jian Zou, Zhaohui Huang
    Clinical Cancer Research Jan 2018, clincanres.2967.2017; DOI: 10.1158/1078-0432.CCR-17-2967
  • An MLH1 enhancer in colorectal cells
    Qing Liu, Julie A Thoms, Andrea C Nunez, Yizhou Huang, Kathy Knezevic, Deborah Packham, Rebecca C. Poulos, Rachel Williams, Dominik Beck, Nicholas J. Hawkins, Robyn L Ward, Jason W. H. Wong, Luke B Hesson, Mathew A Sloane, John Pimanda
    Clinical Cancer Research Jan 2018, clincanres.3678.2017; DOI: 10.1158/1078-0432.CCR-17-3678
  • IGF2BP3/ABCF1 Define Differential Risk of Ewing Sarcoma Progression
    Caterina Mancarella, Michela Pasello, Selena Ventura, Andrea Grilli, Linda Calzolari, Lisa Toracchio, Pier-Luigi Lollini, Davide Maria Donati, Piero Picci, Stefano Ferrari, Katia Scotlandi
    Clinical Cancer Research Apr 2018, DOI: 10.1158/1078-0432.CCR-17-2602
  • Tumor Features Associated to Immunophenotypes
    David Tamborero, Carlota Rubio-Perez, Ferran Muiños, Radhakrishnan Sabarinathan, Josep M. Piulats, Aura Muntasell, Rodrigo Dienstmann, Nuria Lopez-Bigas, Abel Gonzalez-Perez
    Clinical Cancer Research Apr 2018, DOI: 10.1158/1078-0432.CCR-17-3509
  • MEX3B Mediates Resistance to Cancer Immunotherapy
    Lu Huang, Shruti Malu, Jodi A. McKenzie, Miles C. Andrews, Amjad H. Talukder, Trang Tieu, Tatiana Karpinets, Cara Haymaker, Marie-Andrée Forget, Leila J. Williams, Zhe Wang, Rina M. Mbofung, Zhi-Qiang Wang, Richard Eric Davis, Roger S. Lo, Jennifer A. Wargo, Michael A. Davies, Chantale Bernatchez, Timothy Heffernan, Rodabe N. Amaria, Anil Korkut, Weiyi Peng, Jason Roszik, Gregory Lizée, Scott E. Woodman, Patrick Hwu
    Clinical Cancer Research Mar 2018, DOI: 10.1158/1078-0432.CCR-17-2483
  • MEIS-HOX Proteins in Prostate Cancer Progression
    Raj R. Bhanvadia, Calvin VanOpstall, Hannah Brechka, Nimrod S. Barashi, Marc Gillard, Erin M. McAuley, Juan Manuel Vasquez, Gladell Paner, Wen-Ching Chan, Jorge Andrade, Angelo M. De Marzo, Misop Han, Russell Z. Szmulewitz, Donald J. Vander Griend
    Clinical Cancer Research May 2018, DOI: 10.1158/1078-0432.CCR-17-3673

Pages